Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Strategic Asset Allocation Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Strategic Asset Allocation Index of 22.4% as of June 2023. Strategic assets (PP&E of €1.43 Billion plus long-term investments of €-) total €1.43 Billion, measured against net assets of €6.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Tianjin Zhong Xin Pharmaceutical Group C (2TZ) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Strategic Asset Allocation Index (2013–2021)
This chart shows how Tianjin Zhong Xin Pharmaceutical Group Corporation Limited's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2023, the index stands at 22.4%, representing strategic assets of €1.43 Billion against net assets of €6.39 Billion EUR. For live market cap and overall valuation, see Tianjin Zhong Xin Pharmaceutical Group C market capitalisation.
Annual Strategic Asset Allocation Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Tianjin Zhong Xin Pharmaceutical Group C (2TZ) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 22.8% | €1.49 Billion | €1.49 Billion | €- | €6.51 Billion | ▼ -1.7 pp |
| 2020 | 24.5% | €1.46 Billion | €1.46 Billion | €- | €5.95 Billion | ▼ -0.2 pp |
| 2019 | 24.8% | €1.37 Billion | €1.37 Billion | €- | €5.52 Billion | ▼ -14.3 pp |
| 2018 | 39.0% | €1.97 Billion | €1.20 Billion | €773.01 Million | €5.05 Billion | ▼ -0.3 pp |
| 2017 | 39.3% | €1.82 Billion | €1.08 Billion | €742.49 Million | €4.63 Billion | ▼ -11.2 pp |
| 2016 | 50.5% | €2.17 Billion | €995.40 Million | €1.18 Billion | €4.30 Billion | ▲ +7.7 pp |
| 2015 | 42.8% | €1.76 Billion | €921.48 Million | €835.72 Million | €4.11 Billion | ▼ -16.0 pp |
| 2014 | 58.8% | €1.73 Billion | €870.23 Million | €861.55 Million | €2.95 Billion | ▼ -9.0 pp |
| 2013 | 67.8% | €1.75 Billion | €886.22 Million | €859.60 Million | €2.57 Billion | — |